http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106459093-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2015-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a62f1943e9544069cbf7de5a2533af3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad3a08ca7cdba0ab0a6f63eaebcdf30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49adbb32ec9ee616771276115f3af0fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c668f1890bd48e9b9d9c8ea74a017f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_257d4aff9ede005428dcf06fc3b1dfb7
publicationDate 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106459093-A
titleOfInvention Alkyl and aryl derivatives of 1‑oxa‑4,9‑diazaspiroundecane compounds with multimodal antipain activity
abstract The present invention relates to a compound of general formula (I) having dual pharmacological activity against sigma (σ) receptors and μ-opioid receptors, and more specifically, to a diazaspirodecyl compound having this pharmacological activity. Monoalkane compounds; processes for the preparation of such compounds; pharmaceutical compositions comprising them; and their use in therapy, in particular, in the treatment of pain.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108349998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111263764-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107216335-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108349998-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108349999-A
priorityDate 2014-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4353900-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007058322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005030051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012125613-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466787341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118562367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415086071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90192666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163795624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465493123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433130888

Total number of triples: 40.